7 results
RIPE Therapy - Drug Regimens for Microbiologically Confirmed Pulmonary Tuberculosis - IDSA Guidelines

#Tuberculosis #ActiveTB #RIPE #Therapy
Therapy - Drug Regimens ... - IDSA Guidelines ... #Tuberculosis ... #medications #pharmacology ... #Treatment
Vasculitis Management - ACR/VF 2021 Guidelines for Treatment & Management
 • Giant Cell Arteritis (GCA)
 •
Vasculitis Management - ACR ... Guidelines for Treatment ... Nodosa (PAN) • Granulomatosis ... ACR2021 #Guidelines #algorithm ... #rheumatology
IDSA - Clinical Strategy to Build an Individualized Treatment Regimen for Multi-Drug Resistant Tuberculosis (MDR-TB)
 •
IDSA - Clinical ... Individualized Treatment ... Resistant Tuberculosis ... #pharmacology # ... dosing #idsa #drugs
Granulomatosis with Polyangiitis (GPA) and Microscopic Polyangiitis (MPA) - ANCA Vasculitis Management Algorithm - ACR/VF 2021
Granulomatosis with ... Vasculitis Management Algorithm ... - ACR/VF 2021 Guidelines ... Vasculitis #Management #Treatment ... #rheumatology
Eosinophilic Granulomatosis with Polyangiitis (EGPA) - ANCA Vasculitis Management Algorithm - ACR/VF 2021 Guidelines
 • Active
Eosinophilic Granulomatosis ... Vasculitis Management Algorithm ... - ACR/VF 2021 Guidelines ... Vasculitis #Management #Treatment ... #rheumatology
IDSA Summary of recommendations on drugs for use in a treatment regimen for patients with
multidrug-resistant tuberculosis,
IDSA Summary of ... regimen for patients ... multidrug-resistant tuberculosis ... antimicrobials #pharmacology ... #ebm #idsa
IDSA Recommendations for Treating Mycobacterium Tuberculosis Infection and Disease in HIV-AIDS
Treating LTBI (to prevent TB disease)
Indications:
IDSA Recommendations ... Mycobacterium Tuberculosis ... RAL-based ART regimen ... recommended for all ... infections #HIVAIDS #pharmacology